PIRS - Pieris Pharmaceuticals GAAP EPS of -$0.71 beats by $0.17 revenue of $31.41M beats by $5.97M March, 01 2022 07:18 AM Pieris Pharmaceuticals Inc. Pieris Pharmaceuticals press release (NASDAQ:PIRS): FY GAAP EPS of -$0.71 beats by $0.17. Revenue of $31.41M (+7.1% Y/Y) beats by $5.97M. For further details see: Pieris Pharmaceuticals GAAP EPS of -$0.71 beats by $0.17, revenue of $31.41M beats by $5.97M